Intrinsic Value

Adaptimmune Therapeutics plc (ADAP)

$1.58

+0.01 (+0.00%)

Enterprise Value -2,310,132.58
Net Debt -118.76
Equity Value -2,310,013.82
Shares Outstanding 201.07
Equity Value Per Share -11,488.41



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt